GE Healthcare Life Sciences has significantly increased its focus on life sciences business in India

GE Healthcare works in the primary areas of healthcare systems (diagnostic imaging and clinical systems), medical diagnostics, surgery, healthcare IT solutions and life sciences. Last year, the company substantially increased its commercial footprint and service capabilities in India to cater to the customers' needs faster and more efficiently.

Headquartered in the UK, GE Healthcare is a unit of General Electric Company. Worldwide, GE Healthcare employs more than 46,000 people and serves healthcare professionals and their patients in more than 100 countries.

In fiscal 2009-10, the life sciences revenue of the company is estimated at Rs 120 crore. Though the company experienced a slow growth in 2009, it continues its lead in some of the key segments like chromatographic media and proteomic platforms. GE's Biacore range of products (used in protein interaction studies) is a popular one.

GE Healthcare Life Sciences has been a key supplier of bioprocess, protein purification, chromatography, columns, media and filtration needs to the major players in India in the biotech space. With around 30 years of experience in biopharmaceuticals, GE's products and solutions are renowned for their standard in biopharmaceutical production.

The company has a very strong commercial team in India with offices in Bangalore, Delhi, Chennai, Mumbai, Hyderabad, Kolkata, Lucknow, Pune and Chandigarh. And a highly competent service team to serve customers better and faster. The presence of R&D and training facilities and Fast Trak Global Services at the GE John F Welch Global Research Center at Bangalore further complements their commercial operations, and this is the key to providing complete solution for various needs of all their Indian customers.

GE Healthcare Life Sciences has a portfolio of ready-to-use systems and devices designed for biopharmaceutical production. The ready-to-process portfolio is a range of products designed to meet the biopharmaceutical industry's need for increased speed, simplicity and safety for all areas of bioprocessing - from cell culture and fermentation to final purification.